Xu Zhiwei, Shi Qiuxia, Mei Ju, Tan Yan
Department of Cardiothoracic Surgery, Xinhua Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
Center for Cardiac Intensive Care, Beijing Anzhen Hospital, Beijing Institute of Heart, Lung, and Blood Vessel Diseases, Capital Medical University, Beijing, China.
J Card Surg. 2017 Feb;32(2):133-137. doi: 10.1111/jocs.13085. Epub 2017 Jan 10.
Deciding which prosthetic aortic valve to choose is difficult in adolescents who have not yet met their full growth potential. The aim of this study was to assess long-term outcomes following mechanical aortic valve replacement with aortic root enlargement in adolescents.
Between September 1997 and December 2006, 58 consecutive adolescents (49 male, 9 female, median age 15.5, range 13 to 17 years) underwent mechanical aortic valve replacement with aortic root enlargement. All patients received long-term anticoagulation treatment with warfarin, aiming to maintain an international normalized ratio between 2.0 and 2.5. Follow-up of all patients was closed in December 2015.
The mean size of implanted valves was 20.1 ± 1.3 mm. There were two operative deaths (3.4%) and one late death (1.7%). Mean follow-up was 11.6 ± 3.3 years (range, 8.5 to 15.8 years). Actuarial survival at 15 years was 94.7 ± 3.2%. No patient required a redo procedure. At the latest clinical evaluation, 47 patients (81.0%) were in New York Heart Association functional class I and 8 (13.8%) were in functional class II. Actuarial freedom from valve-related complication was 88.1 ± 2.8% at four years. The mean gradient across the aortic mechanical valve on echocardiography was 13.2 ± 6.3 mmHg (range 6 to 38 mmHg).
Mechanical aortic valve replacement with aortic root enlargement remains an excellent treatment option in adolescents with full growth potential. The mortality is very low and all surviving patients resumed normal lifestyles. It represents a good alternative to allografts and bioprostheses in adolescent patients with aortic valve disease.
对于尚未达到完全生长潜能的青少年而言,决定选用哪种人工主动脉瓣颇具难度。本研究旨在评估青少年行机械主动脉瓣置换并主动脉根部扩大后的长期预后。
1997年9月至2006年12月期间,58例青少年(49例男性,9例女性,中位年龄15.5岁,范围13至17岁)连续接受了机械主动脉瓣置换并主动脉根部扩大手术。所有患者均接受华法林长期抗凝治疗,目标是维持国际标准化比值在2.0至2.5之间。所有患者的随访于2015年12月结束。
植入瓣膜的平均尺寸为20.1±1.3毫米。有2例手术死亡(3.4%)和1例晚期死亡(1.7%)。平均随访时间为11.6±3.3年(范围8.5至15.8年)。15年时的精算生存率为94.7±3.2%。无患者需要再次手术。在最近的临床评估中,47例患者(81.0%)处于纽约心脏协会功能分级I级,8例(13.8%)处于功能分级II级。4年时无瓣膜相关并发症的精算自由度为88.1±2.8%。超声心动图上经主动脉机械瓣膜的平均压差为13.2±6.3毫米汞柱(范围6至38毫米汞柱)。
对于具有完全生长潜能的青少年,机械主动脉瓣置换并主动脉根部扩大仍是一种极佳的治疗选择。死亡率很低,所有存活患者均恢复了正常生活方式。对于患有主动脉瓣疾病的青少年患者,它是同种异体移植物和生物假体的良好替代方案。